Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Identifying Suspicious Skin Lesions with a Noninvasive, Painless Device

Published: Monday, October 28, 2013
Last Updated: Sunday, October 27, 2013
Bookmark and Share
VivaScope®cellular imaging devices from Caliber Imaging & Diagnostics.

One in five Americans will develop skin cancer. According to a 2007 study in Archives of Dermatology, more than 3.5 million skin cancers are diagnosed annually-more new cases than breast, prostate, lung and colon cancers combined.

One might think that most people wouldn't hesitate to consult a dermatologist or their general practitioner about any bump, mole or discoloration on their body, since many skin cancers can now be successfully treated if found sufficiently early.

It is surprising that anyone with a skin lesion would hesitate before seeking medical evaluation - one excuse people give is that if they ignore it, it will just go away. Why else do people wait? Some may honestly believe their moles are nothing to worry about.

Others are terrified that a biopsy would leave a scar, a concern that does hold some validity since the majority of skin lesions are benign, but until recently, could only be proven benign by performing a biopsy and examining the surgically removed tissue under a microscope.

One innovative company, Caliber Imaging & Diagnostics, led by CEO L. Michael Hone, has taken the steam out of that last excuse with their FDA-cleared VivaScope®cellular imaging devices.

These new tools allow physicians to biopsy and technicians to evaluate a patient's skin, at and below the skin surface, using imaging rather than surgical options.

Says Hone: "The best medicine with regard to skin cancer is prevention. One should always consider sun protection, apply SPF-30 every day and wear a hat and sunglasses outdoors. The second-best medicine is to consult one's health care provider immediately when one spots anything that might be the least bit questionable. And when a doctor is consulted, ask if they have a noninvasive way to biopsy skin. Doctors should want to provide patients with a painless, noninvasive optical skin biopsy in lieu of the traditional biopsy to help them make a diagnosis."

The company is already marketing its VivaScope systems, including two handheld VivaScopes, the 1500 and 3000, and the VivaScope 2500 for use in the operating room. Another advantage: no waiting. Obtaining the image takes only five to 10 minutes.

"Our technology can image down into the entire lesion, layer by layer, and immediately help doctors eliminate or diagnose a variety of skin diseases and disorders," says Hone.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Genes That Protect African Children From Developing Malaria Identified
Variations in DNA at a specific location on the genome that protect African children from developing severe malaria, in some cases nearly halving a child’s chance of developing the life-threatening disease, have been identified in the largest genetic association study of malaria to date.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
Dormant Viral Genes May Awaken to Cause ALS
NIH human and mouse study may open an unexplored path for finding treatments.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
Five Genetic Regions Implicated In Cystic Fibrosis Severity
An international consortium of researchers conducted the largest-ever CF genome-wide analysis to find new therapeutic targets.
Greater Understanding Of Polycystic Ovary Syndrome
A new genetic study of over 200,000 women reveals the underlying mechanisms of polycystic ovary syndrome, as well as potential interventions.
New Autism Genes Are Revealed in Largest-Ever Study
Work draws more detailed picture of genetic risk, sheds light on sex differences in diagnosis.
A Fundamental Protection Mechanism Against Formalin In Mammals is Revealed
Formaldehyde, or formalin, is well known to all of us as a common chemical used in many industrial processes and also as a preservative, remarkably we also produce formaldehyde in our bodies.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Genetic Adaptations to Diet and Climate
Researchers found genetic variations in the Inuit of Greenland that reflect adaptations to their specific diet and climate.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos